{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:53:37Z","timestamp":1753440817756,"version":"3.37.3"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110116","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T16:20:06Z","timestamp":1723652406000},"page":"110116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Influence of \u03b22-adrenergic selective agonist formoterol on the motor unit of a mouse model of a congenital myasthenic syndrome with complete VAChT deletion"],"prefix":"10.1016","volume":"260","author":[{"given":"Leonardo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara I.","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila A.C.","family":"Valad\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus P.S.","family":"Magalh\u00e3es-Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1121-4015","authenticated-orcid":false,"given":"Bruna S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Guatimosim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz C.C.","family":"Navegantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline S.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.M.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e2nia F.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Guatimosim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110116_bib1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1212\/WNL.0000000000003720","article-title":"Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndrome","volume":"88","author":"Aran","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2024.110116_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-8993(78)90288-3","article-title":"Direct mapping of \u03b2-adrenergic receptors in the rat central nervous system by a novel fluorescent \u03b2-blocker","volume":"150","author":"Atlas","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110116_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2015.10.006","article-title":"\u03b2 2 -Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)","volume":"85","author":"Bartus","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110116_bib6","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.3390\/ijms22094611","article-title":"Adrenoceptors modulate cholinergic synaptic transmission at the neuromuscular junction","volume":"22","author":"Bukharaeva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110116_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3892\/ol.2011.442","article-title":"Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats","volume":"3","author":"Busquets","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.neuropharm.2024.110116_bib8","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1242\/dev.053348","article-title":"Retrograde influence of muscle fibers on their innervation revealed by a novel marker for slow motoneurons","volume":"137","author":"Chakkalakal","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2024.110116_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JND-170293","article-title":"Beta-2 adrenergic receptor agonists enhance AChR clustering in C2C12 myotubes: implications for therapy of myasthenic disorders","volume":"5","author":"Clausen","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.neuropharm.2024.110116_bib10","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1128\/MCB.00245-09","article-title":"The vesicular acetylcholine transporter is required for neuromuscular development and function","volume":"29","author":"de Castro","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib12","doi-asserted-by":"crossref","first-page":"H655","DOI":"10.1152\/ajpheart.00114.2015","article-title":"Autonomic cardiocirculatory control in mice with reduced expression of the vesicular acetylcholine transporter","volume":"309","author":"Durand","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.neuron.2007.09.001","article-title":"The neurotransmitter cycle and quantal size","volume":"55","author":"Edwards","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110116_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13023-019-1025-5","article-title":"Congenital myasthenic syndromes","volume":"14","author":"Finsterer","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neuropharm.2024.110116_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-03991-2","article-title":"\u03b22 - adrenergic regulation of the neuromuscular transmission and its lipid - dependent switch","author":"Gafurova","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2353\/ajpath.2010.090760","article-title":"Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology","volume":"176","author":"Gehrig","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib17","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1523\/JNEUROSCI.4175-04.2005","article-title":"\u03b2-Adrenergic receptor activation facilitates induction of a protein synthesis-dependent late phase of long-term potentiation","volume":"25","author":"Gelinas","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110116_bib18","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1152\/ajpendo.00503.2015","article-title":"Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis","volume":"310","author":"G\u00f3mez-SanMiguel","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2024.110116_bib19","first-page":"E123","article-title":"Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt","volume":"302","author":"Gon\u00e7alves","year":"2012","journal-title":"Am J Physiol Metab"},{"key":"10.1016\/j.neuropharm.2024.110116_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcsm.12395","article-title":"Insulin\/IGF1 signalling mediates the effects of \u03b2 2 -adrenergic agonist on muscle proteostasis and growth","volume":"10","author":"Gon\u00e7alves","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.neuropharm.2024.110116_bib21","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1038\/s41598-021-88438-7","article-title":"\u03b22-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice","volume":"11","author":"Higashihara","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110116_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mus.10092","article-title":"Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the \u03b22-adrenergic receptor","volume":"25","author":"Hinkle","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2024.110116_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/toxsci\/5.6part2.260","article-title":"Neuromuscular toxicity of pyridostigmine bromide in the diaphragm, extensor digitorum longus, and soleus muscles of the rat","volume":"5","author":"Hudson","year":"1985","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110116_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jnc.13910","article-title":"Deletion of the vesicular acetylcholine transporter from pedunculopontine\/laterodorsal tegmental neurons modifies gait","volume":"140","author":"Janickova","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110116_bib25","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.biocel.2013.07.019","article-title":"Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle","volume":"45","author":"Joassard","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib26","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1111\/febs.15825","article-title":"Motoneuron\u2010specific loss of VAChT mimics neuromuscular defects seen in congenital myasthenic syndrome","volume":"288","author":"Joviano\u2010Santos","year":"2021","journal-title":"FEBS J."},{"issue":"80","key":"10.1016\/j.neuropharm.2024.110116_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.110116_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1073\/pnas.1524272113","article-title":"Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease","volume":"113","author":"Khan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2024.110116_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10571-020-00840-3","article-title":"Adrenaline facilitates synaptic transmission by synchronizing release of acetylcholine quanta from motor nerve endings","volume":"41","author":"Khuzakhmetova","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175298","article-title":"Chemogenetic activation of VGLUT3-expressing neurons decreases movement","volume":"935","author":"Kljakic","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib31","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1523\/JNEUROSCI.0395-13.2013","article-title":"ChAT-ChR2-EYFP mice have enhanced motor endurance but show deficits in attention and several additional cognitive domains","volume":"33","author":"Kolisnyk","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110116_bib32","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/MCB.00996-09","article-title":"Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure","volume":"30","author":"Lara","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbi.2016.05.005","article-title":"Vesicular acetylcholine transporter knock down-mice are more susceptible to inflammation, c- Fos expression and sickness behavior induced by lipopolysaccharide","volume":"57","author":"Leite","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2024.110116_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/nn2053","article-title":"Retrograde regulation of motoneuron differentiation by muscle b -catenin","volume":"11","author":"Li","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110116_bib36","doi-asserted-by":"crossref","unstructured":"Liu, W., Chakkalakal, J. V, n.d The Composition , Development , and Regeneration of Neuromuscular Junctions, 1st ed, Myogenesis in Development and Disease. Elsevier Inc. https:\/\/doi.org\/10.1016\/bs.ctdb.2017.08.005.","DOI":"10.1016\/bs.ctdb.2017.08.005"},{"key":"10.1016\/j.neuropharm.2024.110116_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1152\/physrev.00028.2007","article-title":"Role of \u03b2-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease","volume":"88","author":"Lynch","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110116_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2018.07.002","article-title":"Fast and slow-twitching muscles are differentially affected by reduced cholinergic transmission in mice deficient for VAChT: a mouse model for congenital myasthenia","volume":"120","author":"Magalh\u00e3es-Gomes","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2024.110116_bib39","article-title":"Phenotypical and myopathological consequences of compound heterozygous missense and nonsense variants in slc18a3","volume":"10","author":"Marina","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.110116_bib40","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/hmg\/ddy062","article-title":"The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes","volume":"27","author":"McMacken","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2024.110116_bib41","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/hmg\/ddz059","article-title":"Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome","volume":"28","author":"McMacken","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2024.110116_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2739\/kurumemedj.51.175","article-title":"Immunocytochemical localization of .BETA.2-Adrenergic receptors in the rat spinal cord and their spatial relationships to tyrosine hydroxylase-immunoreactive terminals","volume":"51","author":"Mizukami","year":"2004","journal-title":"Kurume Med. J."},{"key":"10.1016\/j.neuropharm.2024.110116_bib43","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4\u2010diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle\u2010specific kinase autoantibody","volume":"591","author":"Morsch","year":"2013","journal-title":"J Physiol"},{"key":"10.1016\/j.neuropharm.2024.110116_bib44","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/WNL.0000000000003179","article-title":"Variants in SLC18A3 , vesicular acetylcholine transporter, cause congenital myasthenic syndrome","volume":"87","author":"O'Grady","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2024.110116_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043730","article-title":"Clinical and pathologic features of congenital myasthenic syndromes caused by 35 genes\u2014a comprehensive review","author":"Ohno","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110116_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(87)90554-4","article-title":"Autoradiographic evidence for \u03b2-adrenergic receptors on capsaicin-sensitive primary afferent terminals in rat spinal cord","volume":"78","author":"Patterson","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2024.110116_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2006.08.005","article-title":"Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition","volume":"51","author":"Prado","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110116_bib48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/BJ20121662","article-title":"Regulation of cholinergic activity by the vesicular acetylcholine transporter","volume":"450","author":"Prado","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2024.110116_bib49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JND-221646","article-title":"Presynaptic congenital myasthenic syndromes: understanding clinical phenotypes through in vivo models","volume":"10","author":"Pugliese","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.neuropharm.2024.110116_bib50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.nmd.2021.07.400","article-title":"Congenital myasthenic syndromes: where do we go from here?","volume":"31","author":"Ramdas","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.neuropharm.2024.110116_bib51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/ALN.0b013e318291c02e","article-title":"Prolonged administration of pyridostigmine impairs neuromuscular function with and without down-regulation of acetylcholine receptors","volume":"119","author":"Richtsfeld","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2024.110116_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105567","article-title":"Neuromuscular defects after infection with a beta coronavirus in mice","volume":"169","author":"Rossi","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2024.110116_bib54","doi-asserted-by":"crossref","DOI":"10.1007\/s10974-024-09665-9","article-title":"Sympathetic innervation in skeletal muscle and its role at the neuromuscular junction","author":"Rudolf","year":"2024","journal-title":"J. Muscle Res. Cell Motil."},{"key":"10.1016\/j.neuropharm.2024.110116_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12576-013-0253-z","article-title":"Intracellular \u03b22-adrenergic receptor signaling specificity in mouse skeletal muscle in response to single-dose \u03b22-agonist clenbuterol treatment and acute exercise","volume":"63","author":"Sato","year":"2013","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110116_bib57","first-page":"1","article-title":"Muscle plasticity and \u03b22-adrenergic receptors: adaptive responses o f\u03b22-adrenergic receptor expression to muscle hypertrophy and atrophy","author":"Sato","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pathophys.2016.07.002","article-title":"Reduced expression of VAChT increases renal fibrosis","volume":"23","author":"Silva","year":"2016","journal-title":"Pathophysiology"},{"key":"10.1016\/j.neuropharm.2024.110116_bib59","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neuroscience.2019.10.049","article-title":"Diverse effects of noradrenaline and adrenaline on the quantal secretion of acetylcholine at the mouse neuromuscular junction","volume":"423","author":"Tsentsevitsky","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110116_bib60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/ejn.13510","article-title":"Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease","volume":"45","author":"Valad\u00e3o","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110116_bib61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuint.2018.03.007","article-title":"Neuromuscular synapse degeneration without muscle function loss in the diaphragm of a murine model for Huntington's Disease","volume":"116","author":"Valad\u00e3o","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2024.110116_bib62","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1093\/brain\/awz322","article-title":"\u03b22-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure","volume":"142","author":"Vanhaesebrouck","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2024.110116_bib63","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2013.06.012","article-title":"A mouse model of the slow channel myasthenic syndrome: neuromuscular physiology and effects of ephedrine treatment","volume":"248","author":"Webster","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110116_bib64","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/hmg\/ddaa116","article-title":"Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia","volume":"29","author":"Webster","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2024.110116_bib65","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1101\/lm.030411.113","article-title":"Activation of \u03b22-adrenoceptor enhances synaptic potentiation and behavioral memory via cAMP-PKA signaling in the medial prefrontal cortex of rats","volume":"20","author":"Zhou","year":"2013","journal-title":"Learn. Mem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T05:40:35Z","timestamp":1726033235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824002855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"alternative-id":["S0028390824002855"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110116","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of \u03b22-adrenergic selective agonist formoterol on the motor unit of a mouse model of a congenital myasthenic syndrome with complete VAChT deletion","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110116"}}